Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Join SI Premium – FREE
Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect
Analyst, Salveen Richter, said, "Q1/12 EPS is a key event for some, but overshadowed by M&A and binary catalysts for others: We expect Q1/12 earnings to serve as catalysts for Alexion (Nasdaq: ALXN), Dendreon (Nasdaq: DNDN) and potentially Incyte (Nasdaq: INCY) (in-line/beat is anticipated). However, Amylin (Nasdaq: AMLN) and Human Genome (Nasdaq: HGSI) will be buoyed by M&A speculation (rather than EPS), while for Auxilium (Nasdaq: AUXL) and BioMarin (Nasdaq: BMRN) (expect solid top-line Q1) it is all about data. For Savient (Nasdaq: SVNT) and United Therapeutics (Nasdaq: UTHR), company fundamentals will play an important role on top of EPS outlook."
Canaccord rated ALXN, AUXL, BMRN, INCY and UTHR at a 'Buy' rating. DNDN, HGSI, and SVNT at Hold. AMLN at a Sell.
Analyst, Salveen Richter, said, "Q1/12 EPS is a key event for some, but overshadowed by M&A and binary catalysts for others: We expect Q1/12 earnings to serve as catalysts for Alexion (Nasdaq: ALXN), Dendreon (Nasdaq: DNDN) and potentially Incyte (Nasdaq: INCY) (in-line/beat is anticipated). However, Amylin (Nasdaq: AMLN) and Human Genome (Nasdaq: HGSI) will be buoyed by M&A speculation (rather than EPS), while for Auxilium (Nasdaq: AUXL) and BioMarin (Nasdaq: BMRN) (expect solid top-line Q1) it is all about data. For Savient (Nasdaq: SVNT) and United Therapeutics (Nasdaq: UTHR), company fundamentals will play an important role on top of EPS outlook."
Canaccord rated ALXN, AUXL, BMRN, INCY and UTHR at a 'Buy' rating. DNDN, HGSI, and SVNT at Hold. AMLN at a Sell.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Starts Jet2 plc (JET2:LN) (DRTGF) at Buy
- JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
- Oppenheimer Reiterates Outperform Rating on NVIDIA (NVDA) Into EPS
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
